Suppression of Colorectal Oncogenesis by Selenium-Enriched Milk Proteins: Apoptosis and K-ras Mutations
Open Access
- 15 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (12) , 4936-4944
Abstract
The chemical form and bioavailability of dietary selenium may influence its protectiveness against colorectal cancer. Selenium is readily incorporated into milk proteins by feeding cows with selenized-yeast. This study examined whether a dairy source of organic selenium (as milk proteins) is more effective than a yeast source at inhibiting oncogenesis in carcinogen-treated mice and whether it regulates the homeostatic response to carcinogen-induced DNA damage. Dietary interventions are as follows: selenium-enriched milk protein isolate (Tatura-Bio Se; 0.5 or 1 ppm selenium) or milk protein control and selenized-yeast (Sel-Plex; 1 or 4 ppm selenium) with casein or casein alone as control. After 4 weeks on diet, mice received a single azoxymethane (10 mg/kg) injection to induce mutations and were killed 6 hours later. Measures were as follows: plasma selenium, cell proliferation, and acute apoptotic response to azoxymethane (AARGC). Separate groups of mice on the same diets were given 4 weekly azoxymethane (15 mg/kg) injections to induce oncogenesis. Mice were killed 6 or 30 weeks after the last azoxymethane injection. Measures were as follows: aberrant crypt foci (ACF), cancers, and K-ras mutations. Dairy-selenium at 1 ppm significantly suppressed ACF and cancers, whereas yeast-selenium at an equivalent selenium intake had no effect. Dairy-selenium significantly increased plasma selenium levels and AARGC, and reduced cell proliferation and frequency of K-ras mutations in ACF relative to an equivalent dose of selenium from yeast. Selenium-enriched milk protein isolate is superior to selenized-yeast in terms of its bioavailability and capacity to suppress oncogenesis. Suppression may be a consequence of enhanced apoptotic deletion of azoxymethane-induced DNA lesions and the subsequent reduction in frequency of K-ras mutations. [Cancer Res 2008;68(12):4936–44]Keywords
This publication has 40 references indexed in Scilit:
- Selenium Content and Distribution in Cow's Milk Supplemented with Two Dietary Selenium SourcesJournal of Agricultural and Food Chemistry, 2005
- Sulindac corrects defective apoptosis and suppresses azoxymethane‐induced colonic oncogenesis in p53 knockout miceInternational Journal of Cancer, 2005
- Rapid Detection of K-ras Mutations in Bile by Peptide Nucleic Acid-mediated PCR Clamping and Melting Curve Analysis: Comparison with Restriction Fragment Length Polymorphism AnalysisClinical Chemistry, 2004
- Studies with the azoxymethane–rat preclinical model for assessing colon tumor development and chemopreventionEnvironmental and Molecular Mutagenesis, 2004
- K-ras Gene Sequence Effects on the Formation of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)−DNA AdductsChemical Research in Toxicology, 2003
- RESPONSIVENESS OF SELENOPROTEINS TO DIETARY SELENIUM,Annual Review of Nutrition, 1999
- Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study GroupJAMA, 1996
- Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk dietCarcinogenesis, 1994
- Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague—Dawley rats: earliest recognizable precursor lesions of experimental colon cancerCarcinogenesis, 1992
- Cancer mortality correlation studies-III: Statistical associations with dietary selenium intakesBioinorganic Chemistry, 1977